https://www.selleckchem.com/pr....oducts/epacadostat-i
onobese patients. The procedural metrics and outcomes were similar, with the exception of greater radiation exposure among obese patients, especially for the procedures performed using system 1 with fusion alone compared with system 2 (fusion and digital zoom). Obese patients had higher QOL mental scores at 2 and 12 months, with a similar reintervention rate, target vessel outcomes, and survival compared with nonobese patients.The existing information supports the use of this material as described in this safety assessmen
כמו
תגובה
לַחֲלוֹק
